As diagnostic, device, and biopharmaceutical companies continue to respond to the global pandemic with new products and solutions, Beaufort is proud to be actively partnering with these leaders to accelerate their medical innovations in the detection, prevention, and treatment of COVID-19.
Our focus during these rapidly changing times is to provide comprehensive and coordinated resources that can be immediately mobilized to support your research needs — and help speed your product to market. While time is of the essence, we remain committed to delivering the highest quality services, maintaining integrity across all processes and protocols, and ensuring strict adherence to scientific and ethical standards.
Whether you are developing a coronavirus assay, seeking emergency use authorization (EUA) in the United States, emergency market access in Europe or access to other markets, or engaged in vaccine or therapeutics development, Beaufort can provide end-to-end services or fill a specific gap to extend your team’s scientific. regulatory, clinical or quality expertise. Our collaborative and client-driven approach provides seamless integration of all activities so you can quickly and effectively reach your goals and bring much-needed care to patients and healthcare providers around the world.
We are grateful for the trust of our clients and ready to support your innovation.
Helping in the Fight Against COVID-19
Beaufort is on the forefront of the latest insights related to COVID-19 diagnostic testing, device, vaccine and therapeutics development. In addition to our extensive experience across a wide range of respiratory and infectious diseases, we have completed, and are currently managing, multiple COVID-19 projects. Let us share our breadth of services and demonstrate how we can work together to quickly address your urgent needs.
COVID-19 Services & Solutions:
- Clinical Trial Management
- Protocol Development
- On-site and Remote Monitoring
- Sample Acquisition and Management
- Data Management
- Statistical Consulting
- Regulatory Strategy (including country-specific requirements)
- US and OUS Regulatory Agency Support
- Emergency Use Authorization (pre-EUA/EUA) Preparation and Submission
- European Emergency Market Access
- WHO Emergency Use Listing (EUL) Preparation and Submission
- Independent Quality Oversight
- Gap Assessments and Remediation
Beaufort’s Quality Oversight Assessors are currently performing over 100 visits at dozens of clinical trial sites in the U.S. in support of a COVID-19 vaccine trial for a major biotechnology company.
Read more about the importance of independent Quality Oversight and how Beaufort can help optimize your clinical trial during COVID-19.